ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer
Titel:
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer
Auteur:
Marth, Christian Vergote, Ignace Scambia, Giovanni Oberaigner, Willi Clamp, Andrew Berger, Regina Kurzeder, Christian Colombo, Nicoletta Vuylsteke, Peter Lorusso, Domenica Hall, Marcia Renard, Vincent Pignata, Sandro Kristeleit, Rebecca Altintas, Sevilay Rustin, Gordon Wenham, Robert M. Mirza, Mansoor Raza Fong, Peter C. Oza, Amit Monk, Bradley J. Ma, Haijun Vogl, Florian D. Bach, Bruce A.